DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Xiaona Sun(Wuhan University), Junjie Zhang(Qinghai University), Pinghui Feng(University of Southern California), Mi Li(Wuhan University), Hansong Xia(University of Southern California), Alexandre Bélot(Université Claude Bernard Lyon 1), Jun Xie(Jiangnan University), Isabelle Rouvet(Hospices Civils de Lyon), Hong‐Bing Shu(Wuhan University), Jun Zhao(Second Hospital of Tianjin Medical University), Cheng Peng(Changchun University), Ting Liu(Wuhan University), Qing Yang(Guangzhou University of Chinese Medicine), Yu Guo(Wuhan University), Li Zhong(New York University)
Nature Communications
December 3, 2020
10.1038/s41467-020-19941-0
Cited by 132

Related Papers

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
|Science|2020|2.9k
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
|Autoimmunity Reviews|2020|693
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378